Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer

Small cell lung cancer (SCLC) is one of the deadliest cancer types in the world. Despite the high response rate to frontline platinum-containing doublets, relapse is inevitable for the majority of patients and the prognosis is poor. Topotecan, which has limited efficacy, has remained the standard se...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yaru, Zhai, Xiaoyang, Han, Anqin, Zhu, Hui, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599302/
https://www.ncbi.nlm.nih.gov/pubmed/31253167
http://dx.doi.org/10.1186/s13045-019-0753-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599302/
https://www.ncbi.nlm.nih.gov/pubmed/31253167
http://dx.doi.org/10.1186/s13045-019-0753-2

Ejemplares similares